U.S. Will Pay Moderna $176 Million to Develop mRNA Bird Flu Vaccine
Credit: Vigilant News
The United States government will pay vaccine manufacturer Moderna $176 million to develop a new mRNA vaccine to treat bird flu.
The U.S. Department of Health and Human Services will pay Moderna $176 million for a vaccine containing the same mRNA technology as the company’s COVID-19 vaccine.
Bird flu, or H5N1, has been reported in dairy cows and has infected three people in the United States.
In total, 135 dairy herds have been infected with bird flu in 12 states.
BREAKING: The U.S. will pay vaccine maker Moderna $176 million to develop a pandemic vaccine that could be used to treat bird flu in people. https://t.co/TTbPScukYd
— The Associated Press (@AP) July 2,
